Director, US Market Access (Early Pipeline)

Novartis; United States; Remote; USD 195,000 - 361,000; Full time

Job summary

Novartis is seeking a Director, Market Access Early Pipeline in the US, with remote work. You will guide how assets are valued, shape access strategies, and influence investment decisions across R&D, Global Strategy, Clinical Development and US Commercial teams.

You will partner with leaders to develop evidence generation plans, optimize pricing and payer coverage, and ensure commercial viability across indications.

Qualifications

• Bachelor’s degree required; MBA, Health Policy or equivalent preferred.
• Minimum of 7 years of pharmaceutical experience in Market Access, Marketing, Managed Care Finance, Insights & Analytics or Business Development.
• Awareness and understanding of US healthcare dynamics and the drivers of pharmaceutical value.
• Strong interpersonal, communication, and influencing skills with ability to collaborate across a matrix organization.
• Ability to analyze complex business issues and connect commercial, financial, and clinical perspectives to develop enhanced value propositions.
• Desirable: Experience in Oncology therapeutic area.

Responsibilities

• Providing US Market Access forecasting assumptions, including pricing (gross and net) and payer coverage implications.
• Developing strategies to optimize payer coverage, patient affordability, and sales revenue across indications.
• Conducting payer market research and incorporating internal Novartis experience to inform assumptions and recommendations.
• Assessing clinical trial designs for market access risks and opportunities to optimize coverage and patient access.
• Collaborating across US and Global teams to create disease area assessments for assets at proof of concept and to ensure commercial viability.

Skills

Market Access

Payer market research

Cross-functional collaboration

Strategic thinking

Education

Bachelor’s degree

MBA or Health Policy preferred

Job description

Novartis is seeking a Director, Market Access Early Pipeline in the US, with remote work. You will guide how assets are valued, shape access strategies, and influence investment decisions across R&D, Global Strategy, Clinical Development and US Commercial teams.

You will partner with leaders to develop evidence generation plans, optimize pricing and payer coverage, and ensure commercial viability across indications.